Cessation in Non-Daily Smokers

• Status: Completed
• Trial end date: 2019-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine the effect of as-needed oral Nicotine Replacement Therapy (NRT) - 2 mg nicotine gum - for smoking cessation in non-daily, or intermittent, smokers, and to study the process of relapse in ITS, using Ecological Momentary Assessment (EMA).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Brian Primack; University of Pittsburgh
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• 18 years old or older

• Smoking for at least 3 years

• Smoking non-daily for at least one year (< or = 27 days/month)

• Smoke at least weekly

• Intention to quit smoking within the next month and a desire to receive behavioral and medication treatment

• Willing and able to come to the laboratory for 8 visits over a 14-week period, as well as a ninth and final visit 6 months after their quit date

• Willing to monitor behavior via an electronic diary for 8 weeks

• Able to read and write English (in order to understand questionnaires and study instructions)

Exclusion Criteria:

• Regular use of any form of tobacco other than cigarettes

• Recent or severe mental illness (uncontrolled severe depression or mood symptoms, active hallucinations, and or hospitalization in the past month for a psychiatric condition)

• Night and/or 'swing' shift work (which complicates EMA schedules)

• Known plans to relocate or move from the Pittsburgh area within the coming 6 months

• Received cessation treatment within past year

• Use of bupropion or varenicline in past 2 months

• Past use of nicotine gum (to avoid un-blinding)

• Contraindication to NRT

• (for women) Current pregnancy or breastfeeding or plan to become pregnant during the next 2 months

• Member of the same household already participating